BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1037882 FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1 InChI=1S/C20H26F5N3O/c21-19(22)8-4-15(5-9-19)18(29)26-10-13-28-11-6-14(7-12-28)16-2-1-3-17(27-16)20(23,24)25/h1-3,14-15H,4-13H2,(H,26,29) OEXMEESXYABYFA-UHFFFAOYSA-N 466535 4,4-Difluoro-N-(2-{4-[6-(trifluoromethyl)pyridin-2-yl]piperidin-1-yl}ethyl)cyclohexane-carboxamide::US10800755, Example 1::US11014905, Example 1 D(2) dopamine receptor Homo sapiens 0.400 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466535 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466535&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429260 441576241 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037883 FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1 InChI=1S/C20H26F5N3O/c21-19(22)8-4-15(5-9-19)18(29)26-10-13-28-11-6-14(7-12-28)16-2-1-3-17(27-16)20(23,24)25/h1-3,14-15H,4-13H2,(H,26,29) OEXMEESXYABYFA-UHFFFAOYSA-N 466535 4,4-Difluoro-N-(2-{4-[6-(trifluoromethyl)pyridin-2-yl]piperidin-1-yl}ethyl)cyclohexane-carboxamide::US10800755, Example 1::US11014905, Example 1 D(4) dopamine receptor Homo sapiens 11.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466535 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466535&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429260 441576241 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037884 FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1 InChI=1S/C20H26F5N3O/c21-19(22)8-4-15(5-9-19)18(29)26-10-13-28-11-6-14(7-12-28)16-2-1-3-17(27-16)20(23,24)25/h1-3,14-15H,4-13H2,(H,26,29) OEXMEESXYABYFA-UHFFFAOYSA-N 466535 4,4-Difluoro-N-(2-{4-[6-(trifluoromethyl)pyridin-2-yl]piperidin-1-yl}ethyl)cyclohexane-carboxamide::US10800755, Example 1::US11014905, Example 1 5-hydroxytryptamine receptor 1A Human 1144 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466535 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466535&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 142429260 441576241 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037885 FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H26F3N3O2/c20-19(21,22)17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-3,14-15H,4-13H2,(H,23,26) OASSGMBDTDTXKO-UHFFFAOYSA-N 466555 US10800755, Example 11::US11014905, Example 11 D(2) dopamine receptor Homo sapiens 11.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466555&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429261 441576261 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037886 FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H26F3N3O2/c20-19(21,22)17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-3,14-15H,4-13H2,(H,23,26) OASSGMBDTDTXKO-UHFFFAOYSA-N 466555 US10800755, Example 11::US11014905, Example 11 D(4) dopamine receptor Homo sapiens 109 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466555&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429261 441576261 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037887 FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H26F3N3O2/c20-19(21,22)17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-3,14-15H,4-13H2,(H,23,26) OASSGMBDTDTXKO-UHFFFAOYSA-N 466555 US10800755, Example 11::US11014905, Example 11 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466555&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 142429261 441576261 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037888 Cc1cccc(n1)C1CCN(CCNC(=O)C2CC3CCC2O3)CC1 InChI=1S/C20H29N3O2/c1-14-3-2-4-18(22-14)15-7-10-23(11-8-15)12-9-21-20(24)17-13-16-5-6-19(17)25-16/h2-4,15-17,19H,5-13H2,1H3,(H,21,24) JQHNICFXWDNWAO-UHFFFAOYSA-N 466545 US10800755, Example 3::US11014905, Example 3 D(2) dopamine receptor Homo sapiens 7.10 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466545 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466545&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 155922395 441576251 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037889 Cc1cccc(n1)C1CCN(CCNC(=O)C2CC3CCC2O3)CC1 InChI=1S/C20H29N3O2/c1-14-3-2-4-18(22-14)15-7-10-23(11-8-15)12-9-21-20(24)17-13-16-5-6-19(17)25-16/h2-4,15-17,19H,5-13H2,1H3,(H,21,24) JQHNICFXWDNWAO-UHFFFAOYSA-N 466545 US10800755, Example 3::US11014905, Example 3 D(4) dopamine receptor Homo sapiens 198 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466545 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466545&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 155922395 441576251 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037890 Cc1cccc(n1)C1CCN(CCNC(=O)C2CC3CCC2O3)CC1 InChI=1S/C20H29N3O2/c1-14-3-2-4-18(22-14)15-7-10-23(11-8-15)12-9-21-20(24)17-13-16-5-6-19(17)25-16/h2-4,15-17,19H,5-13H2,1H3,(H,21,24) JQHNICFXWDNWAO-UHFFFAOYSA-N 466545 US10800755, Example 3::US11014905, Example 3 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466545 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466545&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 155922395 441576251 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037891 Cc1cccc(n1)C1CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1 InChI=1S/C20H29F2N3O/c1-15-3-2-4-18(24-15)16-7-12-25(13-8-16)14-11-23-19(26)17-5-9-20(21,22)10-6-17/h2-4,16-17H,5-14H2,1H3,(H,23,26) KQNGZWUJPKEOIL-UHFFFAOYSA-N 466547 US10800755, Example 4::US11014905, Example 4 D(2) dopamine receptor Homo sapiens 0.400 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466547 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466547&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 155922396 441576253 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037892 Cc1cccc(n1)C1CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1 InChI=1S/C20H29F2N3O/c1-15-3-2-4-18(24-15)16-7-12-25(13-8-16)14-11-23-19(26)17-5-9-20(21,22)10-6-17/h2-4,16-17H,5-14H2,1H3,(H,23,26) KQNGZWUJPKEOIL-UHFFFAOYSA-N 466547 US10800755, Example 4::US11014905, Example 4 D(4) dopamine receptor Homo sapiens 26.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466547 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466547&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 155922396 441576253 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037893 Cc1cccc(n1)C1CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1 InChI=1S/C20H29F2N3O/c1-15-3-2-4-18(24-15)16-7-12-25(13-8-16)14-11-23-19(26)17-5-9-20(21,22)10-6-17/h2-4,16-17H,5-14H2,1H3,(H,23,26) KQNGZWUJPKEOIL-UHFFFAOYSA-N 466547 US10800755, Example 4::US11014905, Example 4 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466547 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466547&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 155922396 441576253 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037894 COCC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(C)n1 InChI=1S/C19H31N3O2/c1-15-6-5-7-17(21-15)16-8-11-22(12-9-16)13-10-20-18(23)19(2,3)14-24-4/h5-7,16H,8-14H2,1-4H3,(H,20,23) HBHQINPAMGZPQL-UHFFFAOYSA-N 466549 US10800755, Example 5::US11014905, Example 5 D(2) dopamine receptor Homo sapiens 80.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466549 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466549&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 155922397 441576255 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037895 COCC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(C)n1 InChI=1S/C19H31N3O2/c1-15-6-5-7-17(21-15)16-8-11-22(12-9-16)13-10-20-18(23)19(2,3)14-24-4/h5-7,16H,8-14H2,1-4H3,(H,20,23) HBHQINPAMGZPQL-UHFFFAOYSA-N 466549 US10800755, Example 5::US11014905, Example 5 D(4) dopamine receptor Homo sapiens 170 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466549 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466549&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 155922397 441576255 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037896 COCC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(C)n1 InChI=1S/C19H31N3O2/c1-15-6-5-7-17(21-15)16-8-11-22(12-9-16)13-10-20-18(23)19(2,3)14-24-4/h5-7,16H,8-14H2,1-4H3,(H,20,23) HBHQINPAMGZPQL-UHFFFAOYSA-N 466549 US10800755, Example 5::US11014905, Example 5 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466549 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466549&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 155922397 441576255 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037897 COCC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F InChI=1S/C19H28F3N3O2/c1-18(2,13-27-3)17(26)23-9-12-25-10-7-14(8-11-25)15-5-4-6-16(24-15)19(20,21)22/h4-6,14H,7-13H2,1-3H3,(H,23,26) VLVHBCCFLHBDRZ-UHFFFAOYSA-N 466550 US10800755, Example 6::US11014905, Example 6 D(2) dopamine receptor Homo sapiens 37.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466550 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466550&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 155922398 441576256 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037898 COCC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F InChI=1S/C19H28F3N3O2/c1-18(2,13-27-3)17(26)23-9-12-25-10-7-14(8-11-25)15-5-4-6-16(24-15)19(20,21)22/h4-6,14H,7-13H2,1-3H3,(H,23,26) VLVHBCCFLHBDRZ-UHFFFAOYSA-N 466550 US10800755, Example 6::US11014905, Example 6 D(4) dopamine receptor Homo sapiens 101 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466550 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466550&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 155922398 441576256 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037899 COCC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F InChI=1S/C19H28F3N3O2/c1-18(2,13-27-3)17(26)23-9-12-25-10-7-14(8-11-25)15-5-4-6-16(24-15)19(20,21)22/h4-6,14H,7-13H2,1-3H3,(H,23,26) VLVHBCCFLHBDRZ-UHFFFAOYSA-N 466550 US10800755, Example 6::US11014905, Example 6 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466550 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466550&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 155922398 441576256 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037900 COCCC1(CC1)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F InChI=1S/C20H28F3N3O2/c1-28-14-9-19(7-8-19)18(27)24-10-13-26-11-5-15(6-12-26)16-3-2-4-17(25-16)20(21,22)23/h2-4,15H,5-14H2,1H3,(H,24,27) OUSGTICEPNMNCZ-UHFFFAOYSA-N 498178 US11014905, Example 7 D(2) dopamine receptor Homo sapiens 13.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498178&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162369129 459071137 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037901 COCCC1(CC1)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F InChI=1S/C20H28F3N3O2/c1-28-14-9-19(7-8-19)18(27)24-10-13-26-11-5-15(6-12-26)16-3-2-4-17(25-16)20(21,22)23/h2-4,15H,5-14H2,1H3,(H,24,27) OUSGTICEPNMNCZ-UHFFFAOYSA-N 498178 US11014905, Example 7 D(4) dopamine receptor Homo sapiens 43.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498178&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162369129 459071137 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037902 COCCC1(CC1)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F InChI=1S/C20H28F3N3O2/c1-28-14-9-19(7-8-19)18(27)24-10-13-26-11-5-15(6-12-26)16-3-2-4-17(25-16)20(21,22)23/h2-4,15H,5-14H2,1H3,(H,24,27) OUSGTICEPNMNCZ-UHFFFAOYSA-N 498178 US11014905, Example 7 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498178&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 162369129 459071137 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037903 Cc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H29N3O2/c1-15-3-2-4-18(21-15)16-5-10-22(11-6-16)12-9-20-19(23)17-7-13-24-14-8-17/h2-4,16-17H,5-14H2,1H3,(H,20,23) MMZCHCQVBLYIRF-UHFFFAOYSA-N 466552 N-{2-[4-(6-Methylpyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 8::US11014905, Example 8 D(2) dopamine receptor Homo sapiens 1.40 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466552 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466552&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429277 441576258 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037904 Cc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H29N3O2/c1-15-3-2-4-18(21-15)16-5-10-22(11-6-16)12-9-20-19(23)17-7-13-24-14-8-17/h2-4,16-17H,5-14H2,1H3,(H,20,23) MMZCHCQVBLYIRF-UHFFFAOYSA-N 466552 N-{2-[4-(6-Methylpyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 8::US11014905, Example 8 D(4) dopamine receptor Homo sapiens 111 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466552 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466552&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429277 441576258 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037905 Cc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H29N3O2/c1-15-3-2-4-18(21-15)16-5-10-22(11-6-16)12-9-20-19(23)17-7-13-24-14-8-17/h2-4,16-17H,5-14H2,1H3,(H,20,23) MMZCHCQVBLYIRF-UHFFFAOYSA-N 466552 N-{2-[4-(6-Methylpyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 8::US11014905, Example 8 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466552 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466552&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 142429277 441576258 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037906 CC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F InChI=1S/C18H26F3N3O/c1-17(2,3)16(25)22-9-12-24-10-7-13(8-11-24)14-5-4-6-15(23-14)18(19,20)21/h4-6,13H,7-12H2,1-3H3,(H,22,25) WRRJZZBXRRDBBD-UHFFFAOYSA-N 466553 US10800755, Example 9::US11014905, Example 9 D(2) dopamine receptor Homo sapiens 1.10 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466553 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466553&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429268 441576259 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037907 CC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F InChI=1S/C18H26F3N3O/c1-17(2,3)16(25)22-9-12-24-10-7-13(8-11-24)14-5-4-6-15(23-14)18(19,20)21/h4-6,13H,7-12H2,1-3H3,(H,22,25) WRRJZZBXRRDBBD-UHFFFAOYSA-N 466553 US10800755, Example 9::US11014905, Example 9 D(4) dopamine receptor Homo sapiens 8.00 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466553 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466553&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429268 441576259 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037908 CC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F InChI=1S/C18H26F3N3O/c1-17(2,3)16(25)22-9-12-24-10-7-13(8-11-24)14-5-4-6-15(23-14)18(19,20)21/h4-6,13H,7-12H2,1-3H3,(H,22,25) WRRJZZBXRRDBBD-UHFFFAOYSA-N 466553 US10800755, Example 9::US11014905, Example 9 5-hydroxytryptamine receptor 1A Human 2443 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466553 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466553&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 142429268 441576259 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037909 Cc1cccc(n1)C1CCN(CCNC(=O)C(C)(C)C)CC1 InChI=1S/C18H29N3O/c1-14-6-5-7-16(20-14)15-8-11-21(12-9-15)13-10-19-17(22)18(2,3)4/h5-7,15H,8-13H2,1-4H3,(H,19,22) UDFOPUAGEBDRJQ-UHFFFAOYSA-N 466554 US10800755, Example 10::US11014905, Example 10 D(2) dopamine receptor Homo sapiens 1.40 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466554 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466554&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 155922400 441576260 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037910 Cc1cccc(n1)C1CCN(CCNC(=O)C(C)(C)C)CC1 InChI=1S/C18H29N3O/c1-14-6-5-7-16(20-14)15-8-11-21(12-9-15)13-10-19-17(22)18(2,3)4/h5-7,15H,8-13H2,1-4H3,(H,19,22) UDFOPUAGEBDRJQ-UHFFFAOYSA-N 466554 US10800755, Example 10::US11014905, Example 10 D(4) dopamine receptor Homo sapiens 19.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466554 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466554&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 155922400 441576260 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037911 Cc1cccc(n1)C1CCN(CCNC(=O)C(C)(C)C)CC1 InChI=1S/C18H29N3O/c1-14-6-5-7-16(20-14)15-8-11-21(12-9-15)13-10-19-17(22)18(2,3)4/h5-7,15H,8-13H2,1-4H3,(H,19,22) UDFOPUAGEBDRJQ-UHFFFAOYSA-N 466554 US10800755, Example 10::US11014905, Example 10 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466554 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466554&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 155922400 441576260 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037912 FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H26F3N3O2/c20-19(21,22)17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-3,14-15H,4-13H2,(H,23,26) OASSGMBDTDTXKO-UHFFFAOYSA-N 466555 US10800755, Example 11::US11014905, Example 11 D(2) dopamine receptor Homo sapiens 2.10 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466555&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429261 441576261 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037913 FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H26F3N3O2/c20-19(21,22)17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-3,14-15H,4-13H2,(H,23,26) OASSGMBDTDTXKO-UHFFFAOYSA-N 466555 US10800755, Example 11::US11014905, Example 11 D(4) dopamine receptor Homo sapiens 44.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466555&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429261 441576261 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037914 FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H26F3N3O2/c20-19(21,22)17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-3,14-15H,4-13H2,(H,23,26) OASSGMBDTDTXKO-UHFFFAOYSA-N 466555 US10800755, Example 11::US11014905, Example 11 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466555&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 142429261 441576261 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037915 FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1 InChI=1S/C20H24F5N3O/c21-19(22)8-4-15(5-9-19)18(29)26-10-13-28-11-6-14(7-12-28)16-2-1-3-17(27-16)20(23,24)25/h1-3,6,15H,4-5,7-13H2,(H,26,29) CFQKEDUZBWAPMC-UHFFFAOYSA-N 466556 4,4-Difluoro-N-{2-[6-(trifluoromethyl)-3′,6′-dihydro[2,4′-bipyridin]-1′ (2′H)-yl]ethyl}-cyclohexane-1-carboxamide::US10800755, Example 12::US11014905, Example 12 D(2) dopamine receptor Homo sapiens 0.200 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466556 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466556&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429255 441576262 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037916 FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1 InChI=1S/C20H24F5N3O/c21-19(22)8-4-15(5-9-19)18(29)26-10-13-28-11-6-14(7-12-28)16-2-1-3-17(27-16)20(23,24)25/h1-3,6,15H,4-5,7-13H2,(H,26,29) CFQKEDUZBWAPMC-UHFFFAOYSA-N 466556 4,4-Difluoro-N-{2-[6-(trifluoromethyl)-3′,6′-dihydro[2,4′-bipyridin]-1′ (2′H)-yl]ethyl}-cyclohexane-1-carboxamide::US10800755, Example 12::US11014905, Example 12 D(4) dopamine receptor Homo sapiens 4.50 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466556 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466556&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429255 441576262 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037917 FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1 InChI=1S/C20H24F5N3O/c21-19(22)8-4-15(5-9-19)18(29)26-10-13-28-11-6-14(7-12-28)16-2-1-3-17(27-16)20(23,24)25/h1-3,6,15H,4-5,7-13H2,(H,26,29) CFQKEDUZBWAPMC-UHFFFAOYSA-N 466556 4,4-Difluoro-N-{2-[6-(trifluoromethyl)-3′,6′-dihydro[2,4′-bipyridin]-1′ (2′H)-yl]ethyl}-cyclohexane-1-carboxamide::US10800755, Example 12::US11014905, Example 12 5-hydroxytryptamine receptor 1A Human 357 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466556 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466556&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 142429255 441576262 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037918 Cc1cccc(n1)C1=CCN(CCNC(=O)[C@H]2C[C@@H]3CC[C@H]2O3)CC1 InChI=1S/C20H27N3O2/c1-14-3-2-4-18(22-14)15-7-10-23(11-8-15)12-9-21-20(24)17-13-16-5-6-19(17)25-16/h2-4,7,16-17,19H,5-6,8-13H2,1H3,(H,21,24)/t16-,17-,19+/m0/s1 WOHMWCGVHSYPFG-JENIJYKNSA-N 466557 US10800755, Example 13::US11014905, Example 13 D(2) dopamine receptor Homo sapiens 1.10 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466557 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466557&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330155 441576263 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037919 Cc1cccc(n1)C1=CCN(CCNC(=O)[C@H]2C[C@@H]3CC[C@H]2O3)CC1 InChI=1S/C20H27N3O2/c1-14-3-2-4-18(22-14)15-7-10-23(11-8-15)12-9-21-20(24)17-13-16-5-6-19(17)25-16/h2-4,7,16-17,19H,5-6,8-13H2,1H3,(H,21,24)/t16-,17-,19+/m0/s1 WOHMWCGVHSYPFG-JENIJYKNSA-N 466557 US10800755, Example 13::US11014905, Example 13 D(4) dopamine receptor Homo sapiens 24.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466557 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466557&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330155 441576263 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037920 Cc1cccc(n1)C1=CCN(CCNC(=O)[C@H]2C[C@@H]3CC[C@H]2O3)CC1 InChI=1S/C20H27N3O2/c1-14-3-2-4-18(22-14)15-7-10-23(11-8-15)12-9-21-20(24)17-13-16-5-6-19(17)25-16/h2-4,7,16-17,19H,5-6,8-13H2,1H3,(H,21,24)/t16-,17-,19+/m0/s1 WOHMWCGVHSYPFG-JENIJYKNSA-N 466557 US10800755, Example 13::US11014905, Example 13 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466557 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466557&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 146330155 441576263 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037921 Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1 InChI=1S/C20H27F2N3O/c1-15-3-2-4-18(24-15)16-7-12-25(13-8-16)14-11-23-19(26)17-5-9-20(21,22)10-6-17/h2-4,7,17H,5-6,8-14H2,1H3,(H,23,26) SKSOBHHSERUEOI-UHFFFAOYSA-N 466559 US10800755, Example 14::US11014905, Example 14 D(2) dopamine receptor Homo sapiens 0.100 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466559 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466559&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146329996 441576265 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037922 Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1 InChI=1S/C20H27F2N3O/c1-15-3-2-4-18(24-15)16-7-12-25(13-8-16)14-11-23-19(26)17-5-9-20(21,22)10-6-17/h2-4,7,17H,5-6,8-14H2,1H3,(H,23,26) SKSOBHHSERUEOI-UHFFFAOYSA-N 466559 US10800755, Example 14::US11014905, Example 14 D(4) dopamine receptor Homo sapiens 3.00 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466559 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466559&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146329996 441576265 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037923 Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1 InChI=1S/C20H27F2N3O/c1-15-3-2-4-18(24-15)16-7-12-25(13-8-16)14-11-23-19(26)17-5-9-20(21,22)10-6-17/h2-4,7,17H,5-6,8-14H2,1H3,(H,23,26) SKSOBHHSERUEOI-UHFFFAOYSA-N 466559 US10800755, Example 14::US11014905, Example 14 5-hydroxytryptamine receptor 1A Human 2438 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466559 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466559&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 146329996 441576265 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037924 Cc1cccc(n1)C1CCN(CCNC(=O)C2CCCOC2)CC1 InChI=1S/C19H29N3O2/c1-15-4-2-6-18(21-15)16-7-10-22(11-8-16)12-9-20-19(23)17-5-3-13-24-14-17/h2,4,6,16-17H,3,5,7-14H2,1H3,(H,20,23) NKLHZQQLECBIFS-UHFFFAOYSA-N 466560 US10800755, Example 15::US11014905, Example 15 D(2) dopamine receptor Homo sapiens 13.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466560 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466560&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146329997 441576266 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037925 Cc1cccc(n1)C1CCN(CCNC(=O)C2CCCOC2)CC1 InChI=1S/C19H29N3O2/c1-15-4-2-6-18(21-15)16-7-10-22(11-8-16)12-9-20-19(23)17-5-3-13-24-14-17/h2,4,6,16-17H,3,5,7-14H2,1H3,(H,20,23) NKLHZQQLECBIFS-UHFFFAOYSA-N 466560 US10800755, Example 15::US11014905, Example 15 D(4) dopamine receptor Homo sapiens 505 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466560 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466560&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146329997 441576266 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037926 Cc1cccc(n1)C1CCN(CCNC(=O)C2CCCOC2)CC1 InChI=1S/C19H29N3O2/c1-15-4-2-6-18(21-15)16-7-10-22(11-8-16)12-9-20-19(23)17-5-3-13-24-14-17/h2,4,6,16-17H,3,5,7-14H2,1H3,(H,20,23) NKLHZQQLECBIFS-UHFFFAOYSA-N 466560 US10800755, Example 15::US11014905, Example 15 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466560 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466560&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 146329997 441576266 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037927 FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCCOC2)CC1 InChI=1S/C19H24F3N3O2/c20-19(21,22)17-5-1-4-16(24-17)14-6-9-25(10-7-14)11-8-23-18(26)15-3-2-12-27-13-15/h1,4-6,15H,2-3,7-13H2,(H,23,26) LUQGVAHGIPCKGZ-UHFFFAOYSA-N 466561 N-{2-[6-(Trifluoromethyl)-3′,6′-dihydro[2,4′-bipyridin]-1′ (2′H)-yl]ethyl}-tetrahydro-2H-pyran-3-carboxamide::US10800755, Example 16::US11014905, Example 16 D(2) dopamine receptor Homo sapiens 6.00 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466561 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466561&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429276 441576267 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037928 FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCCOC2)CC1 InChI=1S/C19H24F3N3O2/c20-19(21,22)17-5-1-4-16(24-17)14-6-9-25(10-7-14)11-8-23-18(26)15-3-2-12-27-13-15/h1,4-6,15H,2-3,7-13H2,(H,23,26) LUQGVAHGIPCKGZ-UHFFFAOYSA-N 466561 N-{2-[6-(Trifluoromethyl)-3′,6′-dihydro[2,4′-bipyridin]-1′ (2′H)-yl]ethyl}-tetrahydro-2H-pyran-3-carboxamide::US10800755, Example 16::US11014905, Example 16 D(4) dopamine receptor Homo sapiens 27.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466561 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466561&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429276 441576267 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037929 FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCCOC2)CC1 InChI=1S/C19H24F3N3O2/c20-19(21,22)17-5-1-4-16(24-17)14-6-9-25(10-7-14)11-8-23-18(26)15-3-2-12-27-13-15/h1,4-6,15H,2-3,7-13H2,(H,23,26) LUQGVAHGIPCKGZ-UHFFFAOYSA-N 466561 N-{2-[6-(Trifluoromethyl)-3′,6′-dihydro[2,4′-bipyridin]-1′ (2′H)-yl]ethyl}-tetrahydro-2H-pyran-3-carboxamide::US10800755, Example 16::US11014905, Example 16 5-hydroxytryptamine receptor 1A Human 1688 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466561 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466561&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 142429276 441576267 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037930 COCC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(C)n1 InChI=1S/C19H29N3O2/c1-15-6-5-7-17(21-15)16-8-11-22(12-9-16)13-10-20-18(23)19(2,3)14-24-4/h5-8H,9-14H2,1-4H3,(H,20,23) IHQWOBBDTIBCNB-UHFFFAOYSA-N 466562 US10800755, Example 17::US11014905, Example 17 D(2) dopamine receptor Homo sapiens 26.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466562 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466562&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330227 441576268 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037931 COCC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(C)n1 InChI=1S/C19H29N3O2/c1-15-6-5-7-17(21-15)16-8-11-22(12-9-16)13-10-20-18(23)19(2,3)14-24-4/h5-8H,9-14H2,1-4H3,(H,20,23) IHQWOBBDTIBCNB-UHFFFAOYSA-N 466562 US10800755, Example 17::US11014905, Example 17 D(4) dopamine receptor Homo sapiens 91.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466562 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466562&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330227 441576268 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037932 COCC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(C)n1 InChI=1S/C19H29N3O2/c1-15-6-5-7-17(21-15)16-8-11-22(12-9-16)13-10-20-18(23)19(2,3)14-24-4/h5-8H,9-14H2,1-4H3,(H,20,23) IHQWOBBDTIBCNB-UHFFFAOYSA-N 466562 US10800755, Example 17::US11014905, Example 17 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466562 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466562&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 146330227 441576268 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037933 COCC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(n1)C(F)(F)F InChI=1S/C19H26F3N3O2/c1-18(2,13-27-3)17(26)23-9-12-25-10-7-14(8-11-25)15-5-4-6-16(24-15)19(20,21)22/h4-7H,8-13H2,1-3H3,(H,23,26) QKTXOFXCKWUIEE-UHFFFAOYSA-N 466564 US10800755, Example 18::US11014905, Example 18 D(2) dopamine receptor Homo sapiens 21.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466564 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466564&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330226 441576270 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037934 COCC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(n1)C(F)(F)F InChI=1S/C19H26F3N3O2/c1-18(2,13-27-3)17(26)23-9-12-25-10-7-14(8-11-25)15-5-4-6-16(24-15)19(20,21)22/h4-7H,8-13H2,1-3H3,(H,23,26) QKTXOFXCKWUIEE-UHFFFAOYSA-N 466564 US10800755, Example 18::US11014905, Example 18 D(4) dopamine receptor Homo sapiens 19.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466564 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466564&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330226 441576270 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037935 COCC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(n1)C(F)(F)F InChI=1S/C19H26F3N3O2/c1-18(2,13-27-3)17(26)23-9-12-25-10-7-14(8-11-25)15-5-4-6-16(24-15)19(20,21)22/h4-7H,8-13H2,1-3H3,(H,23,26) QKTXOFXCKWUIEE-UHFFFAOYSA-N 466564 US10800755, Example 18::US11014905, Example 18 5-hydroxytryptamine receptor 1A Human 2209 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466564 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466564&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 146330226 441576270 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037936 FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H24F3N3O2/c20-19(21,22)17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-4,15H,5-13H2,(H,23,26) GOLUWUPEFVOPGA-UHFFFAOYSA-N 466565 US10800755, Example 19::US11014905, Example 19 D(2) dopamine receptor Homo sapiens 0.800 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466565 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466565&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330084 441576271 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037937 FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H24F3N3O2/c20-19(21,22)17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-4,15H,5-13H2,(H,23,26) GOLUWUPEFVOPGA-UHFFFAOYSA-N 466565 US10800755, Example 19::US11014905, Example 19 D(4) dopamine receptor Homo sapiens 8.00 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466565 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466565&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330084 441576271 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037938 FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H24F3N3O2/c20-19(21,22)17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-4,15H,5-13H2,(H,23,26) GOLUWUPEFVOPGA-UHFFFAOYSA-N 466565 US10800755, Example 19::US11014905, Example 19 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466565 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466565&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 146330084 441576271 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037939 Cc1cccc(n1)C1CCN(CCNC(=O)C2CCCCO2)CC1 InChI=1S/C19H29N3O2/c1-15-5-4-6-17(21-15)16-8-11-22(12-9-16)13-10-20-19(23)18-7-2-3-14-24-18/h4-6,16,18H,2-3,7-14H2,1H3,(H,20,23) SVXBXQKSARCENJ-UHFFFAOYSA-N 498191 US11014905, Example 20 D(2) dopamine receptor Homo sapiens 6.80 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498191 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498191&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330162 459071149 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037940 Cc1cccc(n1)C1CCN(CCNC(=O)C2CCCCO2)CC1 InChI=1S/C19H29N3O2/c1-15-5-4-6-17(21-15)16-8-11-22(12-9-16)13-10-20-19(23)18-7-2-3-14-24-18/h4-6,16,18H,2-3,7-14H2,1H3,(H,20,23) SVXBXQKSARCENJ-UHFFFAOYSA-N 498191 US11014905, Example 20 D(4) dopamine receptor Homo sapiens 92.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498191 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498191&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330162 459071149 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037941 Cc1cccc(n1)C1CCN(CCNC(=O)C2CCCCO2)CC1 InChI=1S/C19H29N3O2/c1-15-5-4-6-17(21-15)16-8-11-22(12-9-16)13-10-20-19(23)18-7-2-3-14-24-18/h4-6,16,18H,2-3,7-14H2,1H3,(H,20,23) SVXBXQKSARCENJ-UHFFFAOYSA-N 498191 US11014905, Example 20 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498191 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498191&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 146330162 459071149 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037942 FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)[C@H]2C[C@@H]3CC[C@H]2O3)CC1 InChI=1S/C20H26F3N3O2/c21-20(22,23)18-3-1-2-16(25-18)13-6-9-26(10-7-13)11-8-24-19(27)15-12-14-4-5-17(15)28-14/h1-3,13-15,17H,4-12H2,(H,24,27)/t14-,15-,17+/m0/s1 LGQIOUYNFUYGTH-YQQAZPJKSA-N 466567 US10800755, Example 21::US11014905, Example 21 D(2) dopamine receptor Homo sapiens 15.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466567 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466567&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330153 441576273 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037943 FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)[C@H]2C[C@@H]3CC[C@H]2O3)CC1 InChI=1S/C20H26F3N3O2/c21-20(22,23)18-3-1-2-16(25-18)13-6-9-26(10-7-13)11-8-24-19(27)15-12-14-4-5-17(15)28-14/h1-3,13-15,17H,4-12H2,(H,24,27)/t14-,15-,17+/m0/s1 LGQIOUYNFUYGTH-YQQAZPJKSA-N 466567 US10800755, Example 21::US11014905, Example 21 D(4) dopamine receptor Homo sapiens 201 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466567 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466567&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330153 441576273 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037944 FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)[C@H]2C[C@@H]3CC[C@H]2O3)CC1 InChI=1S/C20H26F3N3O2/c21-20(22,23)18-3-1-2-16(25-18)13-6-9-26(10-7-13)11-8-24-19(27)15-12-14-4-5-17(15)28-14/h1-3,13-15,17H,4-12H2,(H,24,27)/t14-,15-,17+/m0/s1 LGQIOUYNFUYGTH-YQQAZPJKSA-N 466567 US10800755, Example 21::US11014905, Example 21 5-hydroxytryptamine receptor 1A Human 2170 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466567 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466567&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 146330153 441576273 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037945 Cc1cccc(n1)C1CCN(CCNC(=O)C2CCOC2)CC1 InChI=1S/C18H27N3O2/c1-14-3-2-4-17(20-14)15-5-9-21(10-6-15)11-8-19-18(22)16-7-12-23-13-16/h2-4,15-16H,5-13H2,1H3,(H,19,22) ATMCUVOQKLCNNV-UHFFFAOYSA-N 466568 US10800755, Example 22::US11014905, Example 22 D(2) dopamine receptor Homo sapiens 58.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466568 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466568&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330163 441576274 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037946 Cc1cccc(n1)C1CCN(CCNC(=O)C2CCOC2)CC1 InChI=1S/C18H27N3O2/c1-14-3-2-4-17(20-14)15-5-9-21(10-6-15)11-8-19-18(22)16-7-12-23-13-16/h2-4,15-16H,5-13H2,1H3,(H,19,22) ATMCUVOQKLCNNV-UHFFFAOYSA-N 466568 US10800755, Example 22::US11014905, Example 22 D(4) dopamine receptor Homo sapiens 2241 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466568 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466568&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330163 441576274 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037947 Cc1cccc(n1)C1CCN(CCNC(=O)C2CCOC2)CC1 InChI=1S/C18H27N3O2/c1-14-3-2-4-17(20-14)15-5-9-21(10-6-15)11-8-19-18(22)16-7-12-23-13-16/h2-4,15-16H,5-13H2,1H3,(H,19,22) ATMCUVOQKLCNNV-UHFFFAOYSA-N 466568 US10800755, Example 22::US11014905, Example 22 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466568 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466568&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 146330163 441576274 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037948 FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOC2)CC1 InChI=1S/C18H24F3N3O2/c19-18(20,21)16-3-1-2-15(23-16)13-4-8-24(9-5-13)10-7-22-17(25)14-6-11-26-12-14/h1-3,13-14H,4-12H2,(H,22,25) GGSIQDWKWRXJBY-UHFFFAOYSA-N 466569 US10800755, Example 23::US11014905, Example 25 D(2) dopamine receptor Homo sapiens 166 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466569 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466569&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330154 441576275 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037949 FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOC2)CC1 InChI=1S/C18H24F3N3O2/c19-18(20,21)16-3-1-2-15(23-16)13-4-8-24(9-5-13)10-7-22-17(25)14-6-11-26-12-14/h1-3,13-14H,4-12H2,(H,22,25) GGSIQDWKWRXJBY-UHFFFAOYSA-N 466569 US10800755, Example 23::US11014905, Example 25 D(4) dopamine receptor Homo sapiens 408 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466569 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466569&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330154 441576275 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037950 FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOC2)CC1 InChI=1S/C18H24F3N3O2/c19-18(20,21)16-3-1-2-15(23-16)13-4-8-24(9-5-13)10-7-22-17(25)14-6-11-26-12-14/h1-3,13-14H,4-12H2,(H,22,25) GGSIQDWKWRXJBY-UHFFFAOYSA-N 466569 US10800755, Example 23::US11014905, Example 25 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466569 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466569&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 146330154 441576275 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037951 Cc1cccc(n1)C1CCN(CCNC(=O)C2CCCO2)CC1 InChI=1S/C18H27N3O2/c1-14-4-2-5-16(20-14)15-7-10-21(11-8-15)12-9-19-18(22)17-6-3-13-23-17/h2,4-5,15,17H,3,6-13H2,1H3,(H,19,22) NNKUZJKXZYNHAK-UHFFFAOYSA-N 466570 US10800755, Example 24::US11014905, Example 24 D(2) dopamine receptor Homo sapiens 27.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466570 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466570&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330164 441576276 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037952 Cc1cccc(n1)C1CCN(CCNC(=O)C2CCCO2)CC1 InChI=1S/C18H27N3O2/c1-14-4-2-5-16(20-14)15-7-10-21(11-8-15)12-9-19-18(22)17-6-3-13-23-17/h2,4-5,15,17H,3,6-13H2,1H3,(H,19,22) NNKUZJKXZYNHAK-UHFFFAOYSA-N 466570 US10800755, Example 24::US11014905, Example 24 D(4) dopamine receptor Homo sapiens 3378 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466570 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466570&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330164 441576276 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037953 Cc1cccc(n1)C1CCN(CCNC(=O)C2CCCO2)CC1 InChI=1S/C18H27N3O2/c1-14-4-2-5-16(20-14)15-7-10-21(11-8-15)12-9-19-18(22)17-6-3-13-23-17/h2,4-5,15,17H,3,6-13H2,1H3,(H,19,22) NNKUZJKXZYNHAK-UHFFFAOYSA-N 466570 US10800755, Example 24::US11014905, Example 24 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466570 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466570&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 146330164 441576276 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037954 FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOC2)CC1 InChI=1S/C18H24F3N3O2/c19-18(20,21)16-3-1-2-15(23-16)13-4-8-24(9-5-13)10-7-22-17(25)14-6-11-26-12-14/h1-3,13-14H,4-12H2,(H,22,25) GGSIQDWKWRXJBY-UHFFFAOYSA-N 466569 US10800755, Example 23::US11014905, Example 25 D(2) dopamine receptor Homo sapiens 20.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466569 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466569&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330154 441576275 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037955 FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOC2)CC1 InChI=1S/C18H24F3N3O2/c19-18(20,21)16-3-1-2-15(23-16)13-4-8-24(9-5-13)10-7-22-17(25)14-6-11-26-12-14/h1-3,13-14H,4-12H2,(H,22,25) GGSIQDWKWRXJBY-UHFFFAOYSA-N 466569 US10800755, Example 23::US11014905, Example 25 D(4) dopamine receptor Homo sapiens 423 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466569 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466569&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330154 441576275 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037956 FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOC2)CC1 InChI=1S/C18H24F3N3O2/c19-18(20,21)16-3-1-2-15(23-16)13-4-8-24(9-5-13)10-7-22-17(25)14-6-11-26-12-14/h1-3,13-14H,4-12H2,(H,22,25) GGSIQDWKWRXJBY-UHFFFAOYSA-N 466569 US10800755, Example 23::US11014905, Example 25 5-hydroxytryptamine receptor 1A Human 3327 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466569 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466569&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 146330154 441576275 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037957 CO[C@H]1CC[C@@H](CC1)C(=O)NCCN1CCC(CC1)c1cccc(C)n1 InChI=1S/C21H33N3O2/c1-16-4-3-5-20(23-16)17-10-13-24(14-11-17)15-12-22-21(25)18-6-8-19(26-2)9-7-18/h3-5,17-19H,6-15H2,1-2H3,(H,22,25)/t18-,19- OFDPWRMPOMJNHU-WGSAOQKQSA-N 466572 US10800755, Example 26::US11014905, Example 26 D(2) dopamine receptor Homo sapiens 79.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466572 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466572&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330165 441576278 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037958 CO[C@H]1CC[C@@H](CC1)C(=O)NCCN1CCC(CC1)c1cccc(C)n1 InChI=1S/C21H33N3O2/c1-16-4-3-5-20(23-16)17-10-13-24(14-11-17)15-12-22-21(25)18-6-8-19(26-2)9-7-18/h3-5,17-19H,6-15H2,1-2H3,(H,22,25)/t18-,19- OFDPWRMPOMJNHU-WGSAOQKQSA-N 466572 US10800755, Example 26::US11014905, Example 26 D(4) dopamine receptor Homo sapiens 1902 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466572 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466572&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330165 441576278 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037959 CO[C@H]1CC[C@@H](CC1)C(=O)NCCN1CCC(CC1)c1cccc(C)n1 InChI=1S/C21H33N3O2/c1-16-4-3-5-20(23-16)17-10-13-24(14-11-17)15-12-22-21(25)18-6-8-19(26-2)9-7-18/h3-5,17-19H,6-15H2,1-2H3,(H,22,25)/t18-,19- OFDPWRMPOMJNHU-WGSAOQKQSA-N 466572 US10800755, Example 26::US11014905, Example 26 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466572 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466572&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 146330165 441576278 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037960 CO[C@H]1CC[C@@H](CC1)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F InChI=1S/C21H30F3N3O2/c1-29-17-7-5-16(6-8-17)20(28)25-11-14-27-12-9-15(10-13-27)18-3-2-4-19(26-18)21(22,23)24/h2-4,15-17H,5-14H2,1H3,(H,25,28)/t16-,17- DFQSHXTUDLODFA-QAQDUYKDSA-N 466573 US10800755, Example 27::US11014905, Example 27 D(2) dopamine receptor Homo sapiens 77.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466573&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330085 441576279 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037961 CO[C@H]1CC[C@@H](CC1)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F InChI=1S/C21H30F3N3O2/c1-29-17-7-5-16(6-8-17)20(28)25-11-14-27-12-9-15(10-13-27)18-3-2-4-19(26-18)21(22,23)24/h2-4,15-17H,5-14H2,1H3,(H,25,28)/t16-,17- DFQSHXTUDLODFA-QAQDUYKDSA-N 466573 US10800755, Example 27::US11014905, Example 27 D(4) dopamine receptor Homo sapiens 2474 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466573&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330085 441576279 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037962 CO[C@H]1CC[C@@H](CC1)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F InChI=1S/C21H30F3N3O2/c1-29-17-7-5-16(6-8-17)20(28)25-11-14-27-12-9-15(10-13-27)18-3-2-4-19(26-18)21(22,23)24/h2-4,15-17H,5-14H2,1H3,(H,25,28)/t16-,17- DFQSHXTUDLODFA-QAQDUYKDSA-N 466573 US10800755, Example 27::US11014905, Example 27 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466573&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 146330085 441576279 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037963 FC(F)(F)Oc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H26F3N3O3/c20-19(21,22)28-17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-3,14-15H,4-13H2,(H,23,26) CRIIWZWMEASXGQ-UHFFFAOYSA-N 466574 US10800755, Example 28::US11014905, Example 28 D(2) dopamine receptor Homo sapiens 28.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466574 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466574&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330152 441576280 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037964 FC(F)(F)Oc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H26F3N3O3/c20-19(21,22)28-17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-3,14-15H,4-13H2,(H,23,26) CRIIWZWMEASXGQ-UHFFFAOYSA-N 466574 US10800755, Example 28::US11014905, Example 28 D(4) dopamine receptor Homo sapiens 104 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466574 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466574&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330152 441576280 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037965 FC(F)(F)Oc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H26F3N3O3/c20-19(21,22)28-17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-3,14-15H,4-13H2,(H,23,26) CRIIWZWMEASXGQ-UHFFFAOYSA-N 466574 US10800755, Example 28::US11014905, Example 28 5-hydroxytryptamine receptor 1A Human 2472 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466574 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466574&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 146330152 441576280 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037966 Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H27N3O2/c1-15-3-2-4-18(21-15)16-5-10-22(11-6-16)12-9-20-19(23)17-7-13-24-14-8-17/h2-5,17H,6-14H2,1H3,(H,20,23) LWUCNZZPRVNCLB-UHFFFAOYSA-N 466575 N-[2-(6-Methyl-3′,6′-dihydro[2,4′-bipyridin]-1′(2′H)-yl) ethyl]-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 29::US11014905, Example 29 D(2) dopamine receptor Homo sapiens 0.400 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466575 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466575&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429259 441576281 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037967 Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H27N3O2/c1-15-3-2-4-18(21-15)16-5-10-22(11-6-16)12-9-20-19(23)17-7-13-24-14-8-17/h2-5,17H,6-14H2,1H3,(H,20,23) LWUCNZZPRVNCLB-UHFFFAOYSA-N 466575 N-[2-(6-Methyl-3′,6′-dihydro[2,4′-bipyridin]-1′(2′H)-yl) ethyl]-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 29::US11014905, Example 29 D(4) dopamine receptor Homo sapiens 22.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466575 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466575&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429259 441576281 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037968 Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H27N3O2/c1-15-3-2-4-18(21-15)16-5-10-22(11-6-16)12-9-20-19(23)17-7-13-24-14-8-17/h2-5,17H,6-14H2,1H3,(H,20,23) LWUCNZZPRVNCLB-UHFFFAOYSA-N 466575 N-[2-(6-Methyl-3′,6′-dihydro[2,4′-bipyridin]-1′(2′H)-yl) ethyl]-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 29::US11014905, Example 29 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466575 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466575&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 142429259 441576281 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037969 Cc1cccc(n1)C1=CCN(CCNC(=O)C(C)(C)C)CC1 InChI=1S/C18H27N3O/c1-14-6-5-7-16(20-14)15-8-11-21(12-9-15)13-10-19-17(22)18(2,3)4/h5-8H,9-13H2,1-4H3,(H,19,22) NSRFWSBDKAVEHH-UHFFFAOYSA-N 466576 2,2-Dimethyl-N-[2-(6-methyl-3′,6′-dihydro[2,4′-bipyridin]-1′ (2′H)-yl)ethyl]propanamide::US10800755, Example 30::US11014905, Example 30 D(2) dopamine receptor Homo sapiens 1.40 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466576 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466576&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429266 441576282 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037970 Cc1cccc(n1)C1=CCN(CCNC(=O)C(C)(C)C)CC1 InChI=1S/C18H27N3O/c1-14-6-5-7-16(20-14)15-8-11-21(12-9-15)13-10-19-17(22)18(2,3)4/h5-8H,9-13H2,1-4H3,(H,19,22) NSRFWSBDKAVEHH-UHFFFAOYSA-N 466576 2,2-Dimethyl-N-[2-(6-methyl-3′,6′-dihydro[2,4′-bipyridin]-1′ (2′H)-yl)ethyl]propanamide::US10800755, Example 30::US11014905, Example 30 D(4) dopamine receptor Homo sapiens 14.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466576 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466576&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429266 441576282 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037971 Cc1cccc(n1)C1=CCN(CCNC(=O)C(C)(C)C)CC1 InChI=1S/C18H27N3O/c1-14-6-5-7-16(20-14)15-8-11-21(12-9-15)13-10-19-17(22)18(2,3)4/h5-8H,9-13H2,1-4H3,(H,19,22) NSRFWSBDKAVEHH-UHFFFAOYSA-N 466576 2,2-Dimethyl-N-[2-(6-methyl-3′,6′-dihydro[2,4′-bipyridin]-1′ (2′H)-yl)ethyl]propanamide::US10800755, Example 30::US11014905, Example 30 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466576 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466576&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 142429266 441576282 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037972 CC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(n1)C(F)(F)F InChI=1S/C18H24F3N3O/c1-17(2,3)16(25)22-9-12-24-10-7-13(8-11-24)14-5-4-6-15(23-14)18(19,20)21/h4-7H,8-12H2,1-3H3,(H,22,25) MLIIQBGETYKWJT-UHFFFAOYSA-N 466577 2,2-Dimethyl-N-{2-[6-(trifluoromethyl)-3′,6′-dihydro[2,4′-bipyridin]-1′ (2′H)-yl]ethyl}propanamide::US10800755, Example 31::US11014905, Example 31 D(2) dopamine receptor Homo sapiens 0.300 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466577 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466577&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429285 441576283 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037973 CC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(n1)C(F)(F)F InChI=1S/C18H24F3N3O/c1-17(2,3)16(25)22-9-12-24-10-7-13(8-11-24)14-5-4-6-15(23-14)18(19,20)21/h4-7H,8-12H2,1-3H3,(H,22,25) MLIIQBGETYKWJT-UHFFFAOYSA-N 466577 2,2-Dimethyl-N-{2-[6-(trifluoromethyl)-3′,6′-dihydro[2,4′-bipyridin]-1′ (2′H)-yl]ethyl}propanamide::US10800755, Example 31::US11014905, Example 31 D(4) dopamine receptor Homo sapiens 2.90 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466577 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466577&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429285 441576283 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037974 CC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(n1)C(F)(F)F InChI=1S/C18H24F3N3O/c1-17(2,3)16(25)22-9-12-24-10-7-13(8-11-24)14-5-4-6-15(23-14)18(19,20)21/h4-7H,8-12H2,1-3H3,(H,22,25) MLIIQBGETYKWJT-UHFFFAOYSA-N 466577 2,2-Dimethyl-N-{2-[6-(trifluoromethyl)-3′,6′-dihydro[2,4′-bipyridin]-1′ (2′H)-yl]ethyl}propanamide::US10800755, Example 31::US11014905, Example 31 5-hydroxytryptamine receptor 1A Human 1280 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466577 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466577&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 142429285 441576283 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037975 Fc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C18H26FN3O2/c19-17-3-1-2-16(21-17)14-4-9-22(10-5-14)11-8-20-18(23)15-6-12-24-13-7-15/h1-3,14-15H,4-13H2,(H,20,23) BUJBIVXDBXZHAP-UHFFFAOYSA-N 466578 US10800755, Example 32::US11014905, Example 32 D(2) dopamine receptor Homo sapiens 42.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466578 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466578&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330087 441576284 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037976 Fc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C18H26FN3O2/c19-17-3-1-2-16(21-17)14-4-9-22(10-5-14)11-8-20-18(23)15-6-12-24-13-7-15/h1-3,14-15H,4-13H2,(H,20,23) BUJBIVXDBXZHAP-UHFFFAOYSA-N 466578 US10800755, Example 32::US11014905, Example 32 D(4) dopamine receptor Homo sapiens 96.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466578 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466578&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330087 441576284 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037977 Fc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C18H26FN3O2/c19-17-3-1-2-16(21-17)14-4-9-22(10-5-14)11-8-20-18(23)15-6-12-24-13-7-15/h1-3,14-15H,4-13H2,(H,20,23) BUJBIVXDBXZHAP-UHFFFAOYSA-N 466578 US10800755, Example 32::US11014905, Example 32 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466578 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466578&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 146330087 441576284 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037978 COc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H29N3O3/c1-24-18-4-2-3-17(21-18)15-5-10-22(11-6-15)12-9-20-19(23)16-7-13-25-14-8-16/h2-4,15-16H,5-14H2,1H3,(H,20,23) NOINDEFTVTZLJT-UHFFFAOYSA-N 466579 US10800755, Example 33::US11014905, Example 33 D(2) dopamine receptor Homo sapiens 21.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466579&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330158 441576285 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037979 COc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H29N3O3/c1-24-18-4-2-3-17(21-18)15-5-10-22(11-6-15)12-9-20-19(23)16-7-13-25-14-8-16/h2-4,15-16H,5-14H2,1H3,(H,20,23) NOINDEFTVTZLJT-UHFFFAOYSA-N 466579 US10800755, Example 33::US11014905, Example 33 D(4) dopamine receptor Homo sapiens 119 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466579&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146330158 441576285 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037980 COc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H29N3O3/c1-24-18-4-2-3-17(21-18)15-5-10-22(11-6-15)12-9-20-19(23)16-7-13-25-14-8-16/h2-4,15-16H,5-14H2,1H3,(H,20,23) NOINDEFTVTZLJT-UHFFFAOYSA-N 466579 US10800755, Example 33::US11014905, Example 33 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466579&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 146330158 441576285 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037981 FC(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H27F2N3O2/c20-18(21)17-3-1-2-16(23-17)14-4-9-24(10-5-14)11-8-22-19(25)15-6-12-26-13-7-15/h1-3,14-15,18H,4-13H2,(H,22,25) BRSILCSYDNFMAA-UHFFFAOYSA-N 466580 US10800755, Example 34::US11014905, Example 34 D(2) dopamine receptor Homo sapiens 10.00 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466580 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466580&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146329998 441576286 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037982 FC(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H27F2N3O2/c20-18(21)17-3-1-2-16(23-17)14-4-9-24(10-5-14)11-8-22-19(25)15-6-12-26-13-7-15/h1-3,14-15,18H,4-13H2,(H,22,25) BRSILCSYDNFMAA-UHFFFAOYSA-N 466580 US10800755, Example 34::US11014905, Example 34 D(4) dopamine receptor Homo sapiens 56.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466580 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466580&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146329998 441576286 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037983 FC(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H27F2N3O2/c20-18(21)17-3-1-2-16(23-17)14-4-9-24(10-5-14)11-8-22-19(25)15-6-12-26-13-7-15/h1-3,14-15,18H,4-13H2,(H,22,25) BRSILCSYDNFMAA-UHFFFAOYSA-N 466580 US10800755, Example 34::US11014905, Example 34 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466580 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466580&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 146329998 441576286 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037984 O=C(NCCN1CCC(CC1)c1cccc(n1)C#N)C1CCOCC1 InChI=1S/C19H26N4O2/c20-14-17-2-1-3-18(22-17)15-4-9-23(10-5-15)11-8-21-19(24)16-6-12-25-13-7-16/h1-3,15-16H,4-13H2,(H,21,24) AYKNCXDOPYPPJV-UHFFFAOYSA-N 466581 N-{2-[4-(6-Cyanopyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 35::US11014905, Example 35 D(2) dopamine receptor Homo sapiens 278 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466581 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466581&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429258 441576287 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037985 O=C(NCCN1CCC(CC1)c1cccc(n1)C#N)C1CCOCC1 InChI=1S/C19H26N4O2/c20-14-17-2-1-3-18(22-17)15-4-9-23(10-5-15)11-8-21-19(24)16-6-12-25-13-7-16/h1-3,15-16H,4-13H2,(H,21,24) AYKNCXDOPYPPJV-UHFFFAOYSA-N 466581 N-{2-[4-(6-Cyanopyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 35::US11014905, Example 35 D(4) dopamine receptor Homo sapiens 2258 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466581 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466581&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429258 441576287 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037986 O=C(NCCN1CCC(CC1)c1cccc(n1)C#N)C1CCOCC1 InChI=1S/C19H26N4O2/c20-14-17-2-1-3-18(22-17)15-4-9-23(10-5-15)11-8-21-19(24)16-6-12-25-13-7-16/h1-3,15-16H,4-13H2,(H,21,24) AYKNCXDOPYPPJV-UHFFFAOYSA-N 466581 N-{2-[4-(6-Cyanopyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 35::US11014905, Example 35 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466581 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466581&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 142429258 441576287 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037987 Nc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C18H28N4O2/c19-17-3-1-2-16(21-17)14-4-9-22(10-5-14)11-8-20-18(23)15-6-12-24-13-7-15/h1-3,14-15H,4-13H2,(H2,19,21)(H,20,23) MMJQZWCPJZFPIH-UHFFFAOYSA-N 466582 N-{2-[4-(6-Aminopyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 36::US11014905, Example 36 D(2) dopamine receptor Homo sapiens 132 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466582&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429270 441576288 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037988 Nc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C18H28N4O2/c19-17-3-1-2-16(21-17)14-4-9-22(10-5-14)11-8-20-18(23)15-6-12-24-13-7-15/h1-3,14-15H,4-13H2,(H2,19,21)(H,20,23) MMJQZWCPJZFPIH-UHFFFAOYSA-N 466582 N-{2-[4-(6-Aminopyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 36::US11014905, Example 36 D(4) dopamine receptor Homo sapiens 120 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466582&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429270 441576288 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037989 Nc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C18H28N4O2/c19-17-3-1-2-16(21-17)14-4-9-22(10-5-14)11-8-20-18(23)15-6-12-24-13-7-15/h1-3,14-15H,4-13H2,(H2,19,21)(H,20,23) MMJQZWCPJZFPIH-UHFFFAOYSA-N 466582 N-{2-[4-(6-Aminopyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 36::US11014905, Example 36 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466582&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 142429270 441576288 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037990 CNc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H30N4O2/c1-20-18-4-2-3-17(22-18)15-5-10-23(11-6-15)12-9-21-19(24)16-7-13-25-14-8-16/h2-4,15-16H,5-14H2,1H3,(H,20,22)(H,21,24) MAOSODQBBXGYHQ-UHFFFAOYSA-N 466583 N-(2-{4-[6-(Methylamino)pyridin-2-yl]piperidin-1-yl}ethyl)-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 37::US11014905, Example 37 D(2) dopamine receptor Homo sapiens 108 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466583&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429271 441576289 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037991 CNc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H30N4O2/c1-20-18-4-2-3-17(22-18)15-5-10-23(11-6-15)12-9-21-19(24)16-7-13-25-14-8-16/h2-4,15-16H,5-14H2,1H3,(H,20,22)(H,21,24) MAOSODQBBXGYHQ-UHFFFAOYSA-N 466583 N-(2-{4-[6-(Methylamino)pyridin-2-yl]piperidin-1-yl}ethyl)-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 37::US11014905, Example 37 D(4) dopamine receptor Homo sapiens 73.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466583&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429271 441576289 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037992 CNc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C19H30N4O2/c1-20-18-4-2-3-17(22-18)15-5-10-23(11-6-15)12-9-21-19(24)16-7-13-25-14-8-16/h2-4,15-16H,5-14H2,1H3,(H,20,22)(H,21,24) MAOSODQBBXGYHQ-UHFFFAOYSA-N 466583 N-(2-{4-[6-(Methylamino)pyridin-2-yl]piperidin-1-yl}ethyl)-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 37::US11014905, Example 37 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466583&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 142429271 441576289 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 1037993 CN(C)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C20H32N4O2/c1-23(2)19-5-3-4-18(22-19)16-6-11-24(12-7-16)13-10-21-20(25)17-8-14-26-15-9-17/h3-5,16-17H,6-15H2,1-2H3,(H,21,25) CRPFIYXBQORQJX-UHFFFAOYSA-N 466584 N-(2-{4-[6-(Dimethylamino)pyridin-2-yl]piperidin-1-yl}ethyl)-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 38::US11014905, Example 38 D(2) dopamine receptor Homo sapiens 37.0 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466584&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429287 441576290 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 1037994 CN(C)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C20H32N4O2/c1-23(2)19-5-3-4-18(22-19)16-6-11-24(12-7-16)13-10-21-20(25)17-8-14-26-15-9-17/h3-5,16-17H,6-15H2,1-2H3,(H,21,25) CRPFIYXBQORQJX-UHFFFAOYSA-N 466584 N-(2-{4-[6-(Dimethylamino)pyridin-2-yl]piperidin-1-yl}ethyl)-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 38::US11014905, Example 38 D(4) dopamine receptor Homo sapiens 10.00 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466584&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 142429287 441576290 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 1037995 CN(C)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1 InChI=1S/C20H32N4O2/c1-23(2)19-5-3-4-18(22-19)16-6-11-24(12-7-16)13-10-21-20(25)17-8-14-26-15-9-17/h3-5,16-17H,6-15H2,1-2H3,(H,21,25) CRPFIYXBQORQJX-UHFFFAOYSA-N 466584 N-(2-{4-[6-(Dimethylamino)pyridin-2-yl]piperidin-1-yl}ethyl)-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 38::US11014905, Example 38 5-hydroxytryptamine receptor 1A Human >10000 US Patent 10.7270/Q2C53PZQ aid1805576 US11014905 Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J 5/25/2021 11/22/2021 SUMITOMO DAINIPPON PHARMA CO., LTD. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466584&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 142429287 441576290 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7